Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Oi Harada"'
Autor:
Hajime Kuroda, Tsengelmaa Jamiyan, Rin Yamaguchi, Akinari Kakumoto, Akihito Abe, Oi Harada, Atsuko Masunaga
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background In this study, we investigated CD20+ TILs in triple-negative breast cancer (TNBC) and their relationship with T lymphocyte subsets (CD4+, CD8+, CD25+, and FOXP3+), including their combined prognostic value using an immunohistochem
Externí odkaz:
https://doaj.org/article/162ca5d5a81a4077be0deae2afc3dc99
Autor:
Toshiaki Akahane, Naoki Kanomata, Oi Harada, Tetsumasa Yamashita, Junichi Kurebayashi, Akihide Tanimoto, Takuya Moriya
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Next-generation sequencing (NGS) has shown that recurrent/metastatic breast cancer lesions may have additional genetic changes compared with the primary tumor. These additional changes may be related to tumor progression and/or dr
Externí odkaz:
https://doaj.org/article/4a94328c201145c397ad92c2dc7126b0
Autor:
Nozomi Ueno, MD, Hajime Kuroda, MD, Yuji Kozuka, MD, Oi Harada, MD, Hiroyuki Kato, MD, Keiichi Kubota, MD, Yasuo Imai, MD
Publikováno v:
Human Pathology: Case Reports, Vol 10, Iss , Pp 92-95 (2017)
We report a case of dimorphic variant of ductal carcinoma in situ (dimorphic DCIS), composed of an epithelium intermixed with columnar cells and dimorphic cells. The findings of typical DCIS architecture support categorization as DCIS on a low-power
Externí odkaz:
https://doaj.org/article/4eefe9e181ca415a8aa6d008356d9723
Autor:
Shizu Shinohara, Andrey Bychkov, Jijgee Munkhdelger, Kishio Kuroda, Han-Seung Yoon, Shota Fujimura, Kazuhiro Tabata, Bungo Furusato, Daisuke Niino, Shinpei Morimoto, Takashi Yao, Tomoo Itoh, Hajime Aoyama, Naoko Tsuyama, Yoshiki Mikami, Toshitaka Nagao, Tohru Ikeda, Noriyoshi Fukushima, Oi Harada, Takako Kiyokawa, Naoki Yoshimi, Shinichi Aishima, Ichiro Maeda, Ichiro Mori, Koji Yamanegi, Koichi Tsuneyama, Ryohei Katoh, Miki Izumi, Yoshinao Oda, Junya Fukuoka
Publikováno v:
Virchows Archiv. 481:295-305
Consultation by subspecialty experts is the most common mode of rendering diagnosis in challenging cases in pathological practice. Our study aimed to highlight the diagnostic benefits of whole-slide image (WSI)-based remote consultation. We obtained
Autor:
Tsengelmaa Jamiyan, Rin Yamaguchi, A. Masunaga, H. Kuroda, A. Kakumoto, Akihito Abe, Oi Harada
Publikováno v:
Clinical & Translational Oncology
Purpose Immune cells such as cytotoxic T cells, helper T cells, B cells or tumor-associated macrophages (TAMs) contribute to the anti-tumor response or pro-tumorigenic effect in triple negative breast cancer (TNBC). The interrelation of TAMs, T and B
Autor:
Atsuko Masunaga, Akihito Abe, Rin Yamaguchi, Oi Harada, Hajime Kuroda, Akinari Kakumoto, Tsengelmaa Jamiyan
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background In this study, we investigated CD20+ TILs in triple-negative breast cancer (TNBC) and their relationship with T lymphocyte subsets (CD4+, CD8+, CD25+, and FOXP3+), including their combined prognostic value using an immunohistochemical stai
Autor:
Hiroko Masuda, Kenichi Harano, Sakiko Miura, Ying Wang, Yuko Hirota, Oi Harada, Mohit Kumar Jolly, Yuki Matsunaga, Bora Lim, Anita L. Wood, Napa Parinyanitikul, Hee Jin Lee, Gyungyub Gong, Jason T. George, Herbert Levine, Jangsoon Lee, Xiaoping Wang, Anthony Lucci, Arvind Rao, Brock L. Schweitzer, O. Rayne Lawrence, Robert S. Seitz, Stephan W. Morris, David R. Hout, Seigo Nakamura, Savitri Krishnamurthy, Naoto T. Ueno
Publikováno v:
JCO precision oncology. 6
PURPOSE Lehmann et al have identified four molecular subtypes of triple-negative breast cancer (TNBC)—basal-like (BL) 1, BL2, mesenchymal (M), and luminal androgen receptor—and an immunomodulatory (IM) gene expression signature modifier. Our grou
Autor:
Takuya Moriya, Toshiaki Akahane, Tetsumasa Yamashita, Oi Harada, Junichi Kurebayashi, Akihide Tanimoto, Naoki Kanomata
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Background Next-generation sequencing (NGS) has shown that recurrent/metastatic breast cancer lesions may have additional genetic changes compared with the primary tumor. These additional changes may be related to tumor progression and/or drug resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6f56eb7dafca117d1274b500dfc7f56
https://doi.org/10.21203/rs.2.16536/v4
https://doi.org/10.21203/rs.2.16536/v4
Autor:
Tsengelmaa Jamiyan, Atsuko Masunaga, Hajime Kuroda, Akihito Abe, Oi Harada, Bayarmaa Enkhbat, Akinari Kakumoto, Rin Yamaguchi
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background Recent investigations have demonstrated that the tumor microenvironment, including tumor-infiltrating lymphocytes (TILs), is an important factor in tumor growth and development. While the prognostic correlation of tumor-infiltrating T cell
Autor:
Hiroyuki Kato, Yasuo Imai, Keiichi Kubota, Yuji Kozuka, Hajime Kuroda, Oi Harada, Nozomi Ueno
Publikováno v:
Human Pathology: Case Reports, Vol 10, Iss, Pp 92-95 (2017)
We report a case of dimorphic variant of ductal carcinoma in situ (dimorphic DCIS), composed of an epithelium intermixed with columnar cells and dimorphic cells. The findings of typical DCIS architecture support categorization as DCIS on a low-power